MSL Market Analysis: Claims and Premium Trends

Key Takeaways

• Stop‑loss claim frequency up 70% 2023‑2025.
• Large claims over $1M dollars rose >200% since 2023.
• Premiums increasing 9‑12% annually; market hardening.
• Captives represent ~10% of MSL market, providing margin.
• Pharmacy claims share doubled to 30% of stop‑loss.

Summary

Medical stop‑loss (MSL) insurers are facing unprecedented claim frequency and severity, driving a sharp rise in large‑claim payouts. Between 2023 and 2025, claims over $250,000 grew 70%‑115% across thresholds, with dollars for $1 million+ claims up more than 200%. Carriers responded with double‑digit premium hikes and a hardening market, prompting insurers and employers to consider captive structures, now about 10% of the MSL market. The trend is amplified by growing pharmacy claim costs, which now account for roughly 30% of stop‑loss claims.

Pulse Analysis

The medical stop‑loss market is undergoing a seismic shift as claim frequency and severity surge beyond historic norms. Drivers include rising per‑service costs, a higher incidence of complex diagnoses such as cancer and cardiovascular disease, and the rollout of expensive cell‑and‑gene therapies. Data from carriers like Voya, TMHCC and Spring show claim counts above $250,000 climbing 70%‑115% between 2023 and 2025, while dollars tied to million‑dollar claims have more than doubled, underscoring a rapidly deteriorating loss environment.

These claim dynamics have forced carriers into a hardening phase, reflected in double‑digit premium increases and widening loss ratios. Major insurers reported loss‑ratio spikes in 2024, with Cigna pinpointing stop‑loss as the primary catalyst. Premium surveys reveal 9%‑11% hikes in 2025 and expectations of 10%‑12% annual growth moving forward. Simultaneously, pharmacy claims have risen from under 15% to roughly 30% of stop‑loss claims, adding another layer of cost pressure and complicating actuarial forecasts.

In response, employers are turning to captive insurance structures to regain control over their risk profile. Captives now account for about 10% of the MSL market, allowing firms to retain a portion of the margin that would otherwise flow to commercial carriers and to implement proactive claims management. By internalizing risk, captives can offer greater budget certainty, transparent pricing and the flexibility to mitigate volatility in a market where traditional carriers are less willing to underprice. The outlook suggests continued premium escalation unless systemic cost‑containment measures emerge, making captive solutions an increasingly strategic option for cost‑conscious plan sponsors.